Related Experiment Videos
Transplantation: immunogenetic and clinical aspects--part II
Hospital Practice (Office Ed.)
|January 1, 1983
Abstract:
The ultimate goal is not merely to find a better way of treating acute rejection; efforts are now concentrated on prophylactic immunosuppression with low-dose regimens of azathioprine and steroids. In the wings is cyclosporine, a fungal polypeptide that shows great promise in clinical trials. And on the horizon there is hope that monoclonal antibodies may hold the key to prevention.